Trial
NCT02431260
An Open-Label, Dose-Escalation Study of INCB054329 in Patients With Advanced Malignancies
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Incyte Corporation
Collaborators
—
Condition
Solid Tumors and Hematologic Malignancy
Intervention
INCB054329 Monotherapy
Why stopped
As of 31 JAN 2018, the study was terminated by the sponsor due to PK variability.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-06-14